NSE filing, NSE: ANTHEM. Summary written from the filing by ALFA Finder's alert engine.
Anthem Biosciences Ltd: key numbers
- Share price
- ₹854.45
- Market cap
- ₹48,122 Cr
- Revenue (annual)
- ₹2,124 Cr
- Net profit (annual)
- ₹591.8 Cr
- P/E (TTM)
- 83.5×Sector 47.2×
- Promoter holding
- 71.40%-0.02% QoQ
- FII holding
- 3.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anthem Biosciences Ltd
All →Anthem Biosciences Investor Presentation: Key Takeaways
Q2FY27 revenue ₹5,940 Mn (+7.9% YoY), PAT ₹2,115 Mn (+21.9%), EBITDA margin 50.6% including ₹589 Mn other income. H1FY27 revenue fell 7.2%.
Anthem Biosciences Results Update
Anthem Biosciences reported Q2 FY27 consolidated revenue of ₹5,940 Mn, up 7.9% year-on-year, and PAT of ₹2,115 Mn. H1 FY27 PAT rose 7.2% to ₹3,314 Mn.
Anthem Biosciences Q2 FY27 Results: Net Profit ₹211.5 Cr, Up 22.0% YoY
Anthem Biosciences Ltd reported revenue from operations of ₹594 Cr (+7.9% YoY) and net profit of ₹211.5 Cr (+22.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹211.5 Cr · +22.0% YoY
Anthem Biosciences Board Meeting Date
Anthem Biosciences scheduled a Board meeting for November 3, 2026 to approve Q1 and H1 FY27 financial results. The trading window remains closed until November 5, 2026.
Anthem Biosciences Other Announcement
Anthem Biosciences Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. The filing provides the current distribution of promoter and public shareholdings.
Anthem Biosciences Other Announcement
Designated Person Viridity Tone LLP sold shares of Anthem Biosciences Ltd worth ₹82.67 Crore via market sale.
- Value
- ₹82.67 Cr
Other results update announcements
All →Multi Commodity Exchange of India Results Update
MCX reported H1FY27 consolidated revenue of ₹1,502 crore, up 100.8% YoY, and PAT of ₹868 crore. Q2FY27 PAT rose 130.8% YoY to ₹455 crore.
Shanti Gold International Results Update
Shanti Gold reported H1 FY27 revenue of Rs. 1,462.3 crore and PAT of Rs. 80.0 crore. Revenue doubled, but Q2 EBITDA margin compressed to 5.7%.
Aarti Drugs Results Update
Aarti Drugs reports Q2 FY27 revenue of ₹828.8 Crore and PAT of ₹82.8 Crore, up 83% YoY. Results reflect record quarterly EBITDA and margin expansion.
Fine Organic Industries Results Update
Fine Organic reports Q2 FY27 revenue of ₹729.4 Crore and PAT of ₹152.1 Crore, up 40.1%. Results show strong year-on-year growth across revenue, EBITDA and profit.
Jyoti Structures Results Update
Jyoti Structures reported standalone Q2 FY27 total income up 60.2% to Rs 248.57 crore and PAT of Rs 15.37 crore. The order book stood at Rs 4,219 crore as of September 30, 2026.
Samhi Hotels Results Update
SAMHI Hotels reported unaudited Q2 and H1 FY27 results, with Q2 total income up 15.6% to Rs 3,427 Mn and PAT of Rs 411 Mn. Management highlighted same-store growth and a pipeline of about 1,700 new rooms through FY2031.